a b s t r a c t
This data article contains information on glutathione sulfonamide (GSA) structural confirmation and purity after synthesis, as well as mass spectrometry acquisition parameters for the determination of GSA and other biomarkers for the early assessment of intraamniotic fluid infection in amniotic fluid samples (Cháfer-Pericás et al., 2015) [1] . GSA standards were synthesized and structural confirmation was carried out employing time-of-flight mass spectrometry (TOF-MS); purity was assessed by high performance liquid chromatography (HPLC) with UV detection. For optimization of the acquisition parameters of GSA and other biomarkers, individual analytical standard solution at a concentration of 1 mmol L À 1 was injected into an 
TOF-MS, HPLC-UV, LC-ESI( þ)-MS/MS

Data format Structural confirmation/purity & LC-MS/MS acquisition parameters Experimental factors
None applied
Experimental features
TOF-MS for structural elucidation and HPLC-UV for purity assessment of synthetized GSA; LC-ESI( þ)-MS/MS acquisition parameters for each biomarker Data source location
Valencia, Spain
Data accessibility Data are with this article
Value of the data
GSA standard was synthetized and its molecular structure was confirmed by TOF-MS. Purity of the GSA standard was assessed employing HPLC-UV. LC-MS/MS for the simultaneous quantification of potential biomarkers in small sample volumes. MRM acquisition enabling a highly specific and sensitive analytical response. Linear response curves for each biomarker normalized by peak area values obtained from internal standard solutions for improved reproducibility.
Data, materials and methods
GSA standards
GSA was synthesized and purified as described by Harwood et al. [2] by treating an aqueous GSH solution with hypochlorite solution in phosphate buffer (pH 7.4) at an equimolar ratio (100 mmol L À 1 ) at room temperature. GSA was purified by manual collection of fractions from a Shimadzu Scientific Instruments (Columbia, MD, USA) high performance liquid chromatographic (HPLC) system equipped with a Halo C18 column (2.1 Â 100 mm, 2.7 mm) from Advanced Materials Technology (Wilmington, DE, USA) and using an injection volume of 50 mL. Chromatograms were acquired using UV detection at 222 and 254 nm. Separation was achieved using an H 2 O (0.1% formic acid): methanol gradient and a flow rate of 0.5 mL min À 1 ; gradient conditions were set as follows: from 0 to 3 min 2% methanol; from 3 to 6 min from 2% to 98% methanol; from 6 to 10 min 98% methanol; from 10 to 10.1 min from 98% to 2% methanol and from 10.1 to 14 min 2% methanol. The collected fractions were lyophilized to obtain a fluffy white powder which at À 20°C was stable over a period of several months. In the obtained fractions, the presence of GSA was confirmed by recording full scan direct infusion TOF-MS spectra employing an ABSciex 5600-Triple TOF-MS spectrometer (Framingham, MA, USA) operating in the ESI þ mode. Fig. 1 shows a TOF-MS spectrum of a GSA containing fraction in the region between 250 and 400 m/z. Four peaks with intensities 4500 counts were identified and three of them could be assigned to the molecular ion of GSA and GSA adducts, respectively. The purity of the obtained GSA was determined from three independent runs to be 91 72% employing the above-described HPLC-UV method and measuring the GSA peak area vs. the total area under the curve in chromatograms recorded at 254 nm. Fig. 2 shows chromatograms of a GSA containing fraction and a blank injection.
LC-MS/MS acquisition parameters for biomarker determination in AF samples
An Acquity -Xevo TQ from Waters (Milford, MA, USA) operating in the ESI þ mode was used for the analysis of standard solutions and processed amniotic fluid samples (details can be found in [1] ). Parameters were set as follows: capillary voltage was 3.2 kV, source temperature was 150°C, Table 1 . MassLynx 4.1 and QuanLynx 4.1 from Waters (Milford, MA, USA) were used for data acquisition and processing, respectively. Linear response curves were calculated for each biomarker normalizing with peak areas of internal standards. CE: collision energy; 3NO 2 -Tyr: 3-nitro-tyrosine; 3Cl-Tyr: 3-chloro-tyrosine; 8OHdG: 8-hydroxy-2' -deoxyguanosine; GSA: glutathione sulfonamide; GSSG: oxidized glutathione; 8OHdG-C13N15: 8-hydroxy-2'-deoxyguanosine-C13,N15; Phe-D5: phenylalanine-D5, Meth-D3: methionine-D3.
